Evercore ISI on HELIOS-B Read-Through to BridgeBio Pharma (BBIO)
Tweet Send to a Friend
Evercore ISI analyst Cory Kasimov reiterated an Outperform rating and $50.00 price target on BridgeBio Pharma (NASDAQ: BBIO).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
